Author:
Presant Cary A.,Bosserman Linda,Young Traci,Vakil Mayank,Horns Richard,Upadhyaya Gargi,Ebrahimi Behnam,Yeon Christina,Howard Frank
Reference11 articles.
1. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial;Osborne;J Clin Oncol,2002
2. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate;Dombernowsky;J Clin Oncol,1998
3. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxefen in postmenopausal women;Whelan;J Clin Oncol,2005
4. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer;Coombes;N Eng J Med,2004
5. Clinical features of joint symptoms observed in the arimidex, tamoxifen, alone or in combination (ATAC) trial;Buzdar;J Clin Oncol,2006
Cited by
108 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献